Idera Pharmaceuticals Announces Issuance of Patents Claiming Novel Immune Modulatory Oligonucleotides Targeting ... (Business Wire via Yahoo! Finance)

CAMBRIDGE, Mass.----Idera Pharmaceuticals, Inc. today announced the issuance of several patents. The claims of these patents cover novel immune modulatory oligonucleotides and chemical modifications of IMOs, each of which provide unique immune responses.

Source: http://us.rd.yahoo.com/dailynews/rss/search/Patents/SIG=11rtu416e/*http%3A//biz.yahoo.com/bw/080408/20080408005265.html?.v=1